His main research concerns Virology, Epitope, Antibody, Molecular biology and Glycoprotein. John P. Moore combines topics linked to Immunology with his work on Virology. His Epitope research is multidisciplinary, relying on both Protein structure, Viral replication and Glycan.
His Antibody study combines topics from a wide range of disciplines, such as Recombinant DNA and Antigen. His Molecular biology research focuses on subjects like Lipid bilayer fusion, which are linked to Signal transduction. His Glycoprotein research incorporates themes from Glycoprotein complex, Cleavage and Gp41.
The scientist’s investigation covers issues in Virology, Antibody, Glycoprotein, Epitope and Virus. He interconnects Immunology, Gp41 and Monoclonal antibody in the investigation of issues within Virology. Many of his studies on Antibody involve topics that are commonly interrelated, such as Immune system.
His Glycoprotein study incorporates themes from Antigen, Immunogenicity and Recombinant DNA. His work in Epitope tackles topics such as Glycan which are related to areas like Glycosylation. His work in Virus covers topics such as CCR5 receptor antagonist which are related to areas like Vicriviroc.
His primary areas of investigation include Virology, Antibody, Glycoprotein, Epitope and Glycan. His work is dedicated to discovering how Virology, Immunogenicity are connected with Viral protein and Molecular biology and other disciplines. His Antibody research is multidisciplinary, incorporating perspectives in Virus and Immune system.
His Glycoprotein study integrates concerns from other disciplines, such as Biophysics, Immunogen, Recombinant DNA and Antigen. The concepts of his Epitope study are interwoven with issues in Protein structure, Antigenicity and Monoclonal antibody. His study in Glycan is interdisciplinary in nature, drawing from both Allosteric regulation, Glycosylation, Protomer and Lipid bilayer fusion.
His scientific interests lie mostly in Virology, Epitope, Glycoprotein, Antibody and Glycan. Within one scientific family, John P. Moore focuses on topics pertaining to Immunogenicity under Virology, and may sometimes address concerns connected to Neutralizing antibody. His research integrates issues of Protein structure, Molecular biology and Binding site in his study of Epitope.
His Glycoprotein research is multidisciplinary, incorporating elements of Immunogen, Hiv 1 envelope and Germline. His Antibody study necessitates a more in-depth grasp of Immunology. His biological study spans a wide range of topics, including Lipid bilayer fusion, Glycosylation, Cell biology, Computational biology and Allosteric regulation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.
Tatjana Dragic;Virginia Litwin;Graham P. Allaway;Scott R. Martin.
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
Alexandra Trkola;Tatjana Dragic;James Arthos;James M. Binley.
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.
A Trkola;M Purtscher;T Muster;C Ballaun.
Journal of Virology (1996)
A new classification for HIV-1
E. A. Berger;R. W. Doms;E.-M. Fenyö;B. T. M. Korber.
HIV vaccine design and the neutralizing antibody problem
Dennis R Burton;Ronald C Desrosiers;Robert W Doms;Wayne C Koff.
Nature Immunology (2004)
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.
Michael B. Zwick;Aran F. Labrijn;Meng Wang;Catherine Spenlehauer.
Journal of Virology (2001)
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
G A Donzella;D Schols;S W Lin;J A Esté.
Nature Medicine (1998)
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.
M Thali;J P Moore;C Furman;M Charles.
Journal of Virology (1993)
The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.
Rogier W. Sanders;Miro Venturi;Linnea Schiffner;Roopa Kalyanaraman.
Journal of Virology (2002)
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
Q J Sattentau;J P Moore.
Journal of Experimental Medicine (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: